NY State Senate Bill 2019-S1237

Senate Bill S1237

2019-2020 Legislative Session

Requires the commissioner of health to develop guidelines for the prescription of opioid antagonists

download bill text pdf

Archive: Last Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 08, 2020	referred to health
Jan 11, 2019	referred to health

co-Sponsors

2019-S1237 (ACTIVE) - Details

Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Add §3346, Pub Health L
Versions Introduced in 2017-2018 Legislative Session:: S7801

2019-S1237 (ACTIVE) - Summary

Requires the commissioner of health to develop guidelines for the prescription of opioid antagonists.

2019-S1237 (ACTIVE) - Sponsor Memo

                                
 
BILL NUMBER: S1237

SPONSOR: AMEDORE
 
TITLE OF BILL:

An act to amend the public health law, in relation to requiring the
commissioner of health to develop guidelines for the prescribing of
opioid antagonists

 
PURPOSE:

To require the commissioner of health to develop guidelines for medical
professionals regarding the co-prescribing of opioid antagonists (nalox-
one) along with opioid medications.

 
SUMMARY OF PROVISIONS:

Section one directs the Commissioner of Heath to adopt guidelines for
the prescribing of opioid antagonists, applicable to all licensed health
care providers who are authorized to prescribe an opioid analgesic. The
guidelines are to specifically address:

òprescribing an opioid antagonist (naloxone) to someone to whom an
opioid medication is also prescribed;

òidentifying patients at risk of an opioid-related drug overdose and
prescribing an opioid antagonist to that person or to a person in a
position to administer the opioid antagonist to the patient.

In developing the guidelines, the Commissioner is directed to consult
with the State Board of Pharmacy and utilize materials from the
Substance Abuse and Mental Health Services Administration, part of the
US Department of Health & Human Services, as well as publications form
the medical profession.

Section two provides the effective date.

 
JUSTIFICATION:

The federal Substance Abuse and Mental Health Service Administration
recommends that naloxone be prescribed along with and opioid
prescriptions for certain individuals who may be at high risk of opioid
overdose.

Eleven states have co-prescribing guidelines. A wide range of profes-
sional health organizations, including the American Medial Association,
the World Health Organization and the Centers for Disease Prevention &
Control, supports the co-prescribing of naloxone to at-risk patients.

 
LEGISLATIVE HISTORY:

2018: S.7801 - Referred to Committee on Health.

 
FISCAL IMPLICATIONS:

None.

 
EFFECTIVE DATE:
One hundred eighty days after it shall have become law; effective imme-
diately, the addition, amendment and/or repeal of any rule or regulation
necessary for the implementation of this act on its effective date are
authorized to be made and completed on or before such date.

2019-S1237 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   1237
 
                        2019-2020 Regular Sessions
 
                             I N  S E N A T E
 
                             January 11, 2019
                                ___________
 
 Introduced  by  Sens. AMEDORE, AKSHAR -- read twice and ordered printed,
   and when printed to be committed to the Committee on Health
 
 AN ACT to amend the public health law,  in  relation  to  requiring  the
   commissioner  of  health  to develop guidelines for the prescribing of
   opioid antagonists

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  The  public health law is amended by adding a new section
 3346 to read as follows:
   § 3346. GUIDELINES FOR THE PRESCRIBING OF OPIOID ANTAGONISTS. 1.   THE
 COMMISSIONER SHALL ADOPT GUIDELINES FOR THE PRESCRIBING OF OPIOID ANTAG-
 ONISTS  THAT ARE APPLICABLE TO ALL LICENSED HEALTH CARE PROVIDERS IN THE
 STATE WHO ARE AUTHORIZED TO PRESCRIBE AN OPIOID ANALGESIC.  SUCH  GUIDE-
 LINES MUST ADDRESS:
   (A)  PRESCRIBING  AN  OPIOID ANTAGONIST TO A PATIENT TO WHOM AN OPIOID
 MEDICATION IS ALSO PRESCRIBED; AND
   (B) IDENTIFYING PATIENTS AT RISK OF AN  OPIOID-RELATED  DRUG  OVERDOSE
 AND PRESCRIBING AN OPIOID ANTAGONIST TO THAT PATIENT OR TO A PERSON IN A
 POSITION TO ADMINISTER THE OPIOID ANTAGONIST TO THAT PATIENT.
   2.  IN  ADOPTING GUIDELINES UNDER THIS SECTION, THE COMMISSIONER SHALL
 CONSULT WITH THE STATE BOARD OF PHARMACY AS WELL AS MATERIALS  PUBLISHED
 BY,  BUT  NOT LIMITED TO, THE SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES
 ADMINISTRATION OF THE UNITED  STATES  DEPARTMENT  OF  HEALTH  AND  HUMAN
 SERVICES  AND  OTHER  APPROPRIATE  MATERIALS, INCLUDING MEDICAL JOURNALS
 SUBJECT TO PEER REVIEW AND PUBLICATIONS BY MEDICAL PROFESSIONAL  ASSOCI-
 ATIONS.
   3.  THE COMMISSIONER IS AUTHORIZED TO PROMULGATE RULES AND REGULATIONS
 NECESSARY FOR THE IMPLEMENTATION OF THIS SECTION.
   § 2. This act shall take effect on the one hundred eightieth day after
 it shall have become a law. Effective immediately, the addition,  amend-
 ment and/or repeal of any rule or regulation necessary for the implemen-
 tation  of  this act on its effective date are authorized to be made and
 completed on or before such date.

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD01603-01-9

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S1237

Share this bill

Sponsored By

George Amedore